CD22 antigen peptide QLQWLLEGV (HLA-A*0201)

IBA Lifescience Kontakt z doradcą
Single peptide synthesized as presented by the MHC class I allele
CD22 antigen peptide QLQWLLEGV (HLA-A*0201)

CD22 antigen peptide QLQWLLEGV (HLA-A*0201) is a single peptide for stimulation of T cells. The peptide from B cell receptor CD22 is synthesized as it is presented by the MHC class I HLA-A*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.

Specifications

  • Form: Lyophilized powder
  • Peptide Sequence: QLQWLLEGV
  • Possible Application: T cell stimulation
  • Purity: > 85%
  • Sterility: Sterile
  • MHC I Compatibility: HLA-A*0201

Podobne produkty

CD31 Fab-Strep, human

CD31 Fab-Strep, human

IBA Lifescience
Więcej
CD22 antigen peptide SLPYHSQKL (HLA-A*0201)

CD22 antigen peptide SLPYHSQKL (HLA-A*0201)

IBA Lifescience
Więcej
ADV E1A peptide LLDQLIEEV (HLA-A*0201)

ADV E1A peptide LLDQLIEEV (HLA-A*0201)

IBA Lifescience
Więcej